MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Precipio Depreciation & Amortization 2011-2026 | PRPO
Annual Depreciation & Amortization Precipio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.22 M | 1.22 M | 1.13 M | 1.09 M | 1.12 M | 1.26 M | 743 K | 112 K | 489 K | 569 K | 2.75 M | 2.28 M | 2.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.75 M | 112 K | 1.24 M |
Quarterly Depreciation & Amortization Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 324 K | - | - | - | 304 K | - | - | - | 310 K | - | 910 K | 604 K | 302 K | - | 835 K | 549 K | 268 K | - | 829 K | 564 K | 281 K | - | 838 K | 560 K | 277 K | - | 972 K | 680 K | 352 K | - | 395 K | 48 K | 24 K | - | 99 K | 55 K | 83 K | - | 343 K | 558 K | 41 K | - | 589 K | 488 K | 493 K | - | 671 K | 687 K | 744 K | - | 495 K | 532 K | 513 K | - | 481 K | 499 K | 494 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 972 K | 24 K | 464 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.29 | -12.26 % | $ 1.64 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 39.74 | 1.48 % | $ 1.1 B | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 219.29 | -0.08 % | $ 160 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
DexCom
DXCM
|
186 M | $ 73.31 | -0.93 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 20.55 | -1.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
130 K | $ 109.48 | -2.35 % | $ 4.32 B | USA |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 102.41 | 0.1 % | $ 19 B | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 10.2 | -0.97 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
Guardant Health
GH
|
42.4 M | $ 113.17 | 2.43 % | $ 13.9 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
130 M | $ 672.84 | -0.57 % | $ 55.5 B | USA |
 |
Illumina
ILMN
|
354 M | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
1.11 B | $ 230.33 | -2.19 % | $ 41.8 B | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 210.51 | -0.59 % | $ 10.8 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 66.91 | 0.34 % | $ 4.63 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 186.45 | 2.27 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 10.11 | 4.66 % | $ 1.31 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 271.34 | 0.56 % | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 181.44 | -2.39 % | $ 15 B |  Irlanda |
 |
Medpace Holdings
MEDP
|
27.8 M | $ 582.66 | -1.76 % | $ 18 B | USA |
 |
Agilent Technologies
A
|
321 M | $ 133.33 | 0.07 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.41 | 0.84 % | $ 5.54 M | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
57.4 M | $ 7.86 | 0.51 % | $ 492 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |